abrdn Life Sciences Investors
HQL
75 hedge funds and large institutions have $118M invested in abrdn Life Sciences Investors in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 40 increasing their positions, 13 reducing their positions, and 12 closing their positions.
208% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 13
4% more capital invested
Capital invested by funds: $113M → $118M (+$4.75M)
0.72% less ownership
Funds ownership: 32.49% → 31.77% (-0.72%)
9% less funds holding
Funds holding: 82 → 75 (-7)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.66M |
| 2 |
Morgan Stanley
New York
|
+$3.05M |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$828K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$782K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$518K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIA
Absolute Investment Advisers
Rosemary Beach,
Florida
|
-$2.44M |
| 2 |
SCM
Saba Capital Management
New York
|
-$2.11M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.04M |
| 4 |
QL
Quarry LP
New York
|
-$907K |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$456K |
HQL Hedge Fund Activity: Q2 2025 in Review
75 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2025, worth a combined $118M — up 4.2% from $113M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of HQL and 5 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 40 added.
The largest buyer was Royal Bank of Canada, adding an estimated $4.66M. The largest seller was Absolute Investment Advisers, exiting entirely with an estimated $2.44M sold.
- 75 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2025, down from 82 in Q1 2025.
- Funds reported $118M of abrdn Life Sciences Investors stock for Q2 2025, up 4.2% quarter-over-quarter.
- 5 funds opened new abrdn Life Sciences Investors positions in Q2 2025 and 12 closed out, a net change of -7 holders.
- The largest abrdn Life Sciences Investors buyer in Q2 2025 was Royal Bank of Canada, an estimated $4.66M added.
- The largest abrdn Life Sciences Investors seller in Q2 2025 was Absolute Investment Advisers, an estimated $2.44M sold.
Based on aggregated 13F filings for Q2 2025.